Skip to main content
TipRanks
Go Ultimate75% OFF

Vertex Pharmaceuticals (VX1) Ownership - Who Owns Vertex Pharmaceuticals?

23 Followers

Vertex Pharmaceuticals (VX1) Ownership Overview

  • 0.20% Insiders
  • 35.43% Mutual Funds
  • 27.93% Other Institutional Investors
  • 30.94% ETFs
  • 5.50% Public Companies and Individual Investors

The ownership structure of Vertex Pharmaceuticals (DE:VX1) stock is a mix of institutional, retail, and individual investors. Approximately 94.30% of the company’s stock is owned by Institutional Investors, 0.20% is owned by Insiders, and 5.50% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Antipodes Partners Ltd€57,576
Dec 31, 2025Gallacher Capital Management Llc€374,928
Dec 31, 2025Entrypoint Capital, Llc€483,281
Dec 31, 2025Graham Capital Management, L.p.€540,858

Top Shareholders

DE:VX1 top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.23,803,111Institution9.39%12,782,437,229
Vanguard20,842,798Institution8.22%11,192,728,426
Vanguard Index Funds17,715,576Institution6.99%9,513,388,321
Ishares17,445,631Institution6.88%9,368,425,966
Growth Fund Of America12,908,237Institution5.09%6,931,813,627
Spdr10,557,107Institution4.16%5,669,240,359
Invesco9,987,751Institution3.94%5,363,492,201
Investment Co Of America6,269,142Institution2.47%3,366,573,138
American Balanced Fund5,558,357Institution2.19%2,984,876,617
Amcap Fund4,734,921Institution1.87%2,542,685,721

Top Mutual Fund Holders

DE:VX1 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds17,715,576Institution6.99%9,513,388,321
Growth Fund Of America12,908,237Institution5.09%6,931,813,627
Investment Co Of America6,269,142Institution2.47%3,366,573,138
American Balanced Fund5,558,357Institution2.19%2,984,876,617
Amcap Fund4,734,921Institution1.87%2,542,685,721
Fidelity Concord Street Trust4,575,593Institution1.80%2,457,125,470
New Perspective Fund3,366,011Institution1.33%1,807,571,469
Capital World Growth & Income Fund2,377,362Institution0.94%1,276,660,036
Washington Mutual Investors Fund1,975,814Institution0.78%1,061,025,949
Vanguard Specialized Funds1,890,142Institution0.75%1,015,019,485

FAQ

Who Owns Vertex Pharmaceuticals (DE:VX1)?
According to the latest TipRanks data, approximately 94.30% of the company's stock is held by institutional investors, 0.20% is held by insiders, and 5.50% is held by public companies and individual investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 94.30% of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors: 35.43% by mutual funds, 30.94% by ETFs and 27.93% by other institutional investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by retail investors?
According to the latest TipRanks data, approximately 5.50% of Vertex Pharmaceuticals (DE:VX1) stock is held by public companies and individual investors.
Who owns the most shares of Vertex Pharmaceuticals (DE:VX1)?
BlackRock, Inc. owns the most shares of Vertex Pharmaceuticals (DE:VX1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.